Shimoda, M <br/><br/>
Randomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection.  [electronic resource] 

 -  The British journal of surgery  Jun 2015 
 - 746-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2168 
<br/><br/><label>Standard No.: </label>10.1002/bjs.9775  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Japan--epidemiology<br/>Male<br/>Middle Aged<br/>Oxonic Acid--administration & dosage<br/>Pancreatectomy<br/>Pancreatic Neoplasms--drug therapy<br/>Postoperative Care--methods<br/>Prospective Studies<br/>Survival Rate--trends<br/>Tegafur--administration & dosage<br/>Treatment Outcome<br/>Young Adult<br/>Gemcitabine